166 related articles for article (PubMed ID: 24151537)
1. The Effect of Molecular Weight, PK, and Valency on Tumor Biodistribution and Efficacy of Antibody-Based Drugs.
Muchekehu R; Liu D; Horn M; Campbell L; Del Rosario J; Bacica M; Moskowitz H; Osothprarop T; Dirksen A; Doppalapudi V; Kaspar A; Pirie-Shepherd SR; Coronella J
Transl Oncol; 2013; 6(5):562-72. PubMed ID: 24151537
[TBL] [Abstract][Full Text] [Related]
2. Pretargeting for cancer radioimmunotherapy with bispecific antibodies: role of the bispecific antibody's valency for the tumor target antigen.
Karacay H; Sharkey RM; McBride WJ; Griffiths GL; Qu Z; Chang K; Hansen HJ; Goldenberg DM
Bioconjug Chem; 2002; 13(5):1054-70. PubMed ID: 12236788
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics and biodistribution of genetically-engineered antibodies.
Colcher D; Pavlinkova G; Beresford G; Booth BJ; Choudhury A; Batra SK
Q J Nucl Med; 1998 Dec; 42(4):225-41. PubMed ID: 9973838
[TBL] [Abstract][Full Text] [Related]
4. Valency of CD3 binding and internalization of the CD3 cell-surface complex control T cell responses to second signals: distinction between effects on protein kinase C, cytoplasmic free calcium, and proliferation.
Ledbetter JA; June CH; Martin PJ; Spooner CE; Hansen JA; Meier KE
J Immunol; 1986 Jun; 136(11):3945-52. PubMed ID: 3084650
[TBL] [Abstract][Full Text] [Related]
5. Optimization of IGF-1R SPECT/CT imaging using 111In-labeled F(ab')2 and Fab fragments of the monoclonal antibody R1507.
Heskamp S; van Laarhoven HW; Molkenboer-Kuenen JD; Bouwman WH; van der Graaf WT; Oyen WJ; Boerman OC
Mol Pharm; 2012 Aug; 9(8):2314-21. PubMed ID: 22747077
[TBL] [Abstract][Full Text] [Related]
6. Antibody Fragment F(ab')
Li Q; Peterson N; Hanna RN; Kuszpit K; White J; Allen KL; Barnes A; Rickert KW; Shan L; Wu H; Dall'Acqua WF; Tsui P; Borrok MJ
Mol Pharm; 2020 Feb; 17(2):507-516. PubMed ID: 31841002
[TBL] [Abstract][Full Text] [Related]
7. Preparation, characterization, and in vivo biodistribution properties of synthetically cross-linked multivalent antitumor antibody fragments.
Schott ME; Frazier KA; Pollock DK; Verbanac KM
Bioconjug Chem; 1993; 4(2):153-65. PubMed ID: 7873647
[TBL] [Abstract][Full Text] [Related]
8. Experimental studies on the role of antibody fragments in cancer radio-immunotherapy: Influence of radiation dose and dose rate on toxicity and anti-tumor efficacy.
Behr TM; Memtsoudis S; Sharkey RM; Blumenthal RD; Dunn RM; Gratz S; Wieland E; Nebendahl K; Schmidberger H; Goldenberg DM; Becker W
Int J Cancer; 1998 Aug; 77(5):787-95. PubMed ID: 9688314
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics and tumor targeting of 131I-labeled F(ab')2 fragments of the chimeric monoclonal antibody G250: preclinical and clinical pilot studies.
Brouwers A; Mulders P; Oosterwijk E; Buijs W; Corstens F; Boerman O; Oyen W
Cancer Biother Radiopharm; 2004 Aug; 19(4):466-77. PubMed ID: 15453961
[TBL] [Abstract][Full Text] [Related]
10. Radiolabeled monoclonal antibody 15 and its fragments for localization and imaging of xenografts of human lung cancer.
Endo K; Kamma H; Ogata T
J Natl Cancer Inst; 1988 Aug; 80(11):835-42. PubMed ID: 3392743
[TBL] [Abstract][Full Text] [Related]
11. Comparison of biodistribution of 791T/36 monoclonal antibody and its Fab/c fragment in BALB/c mice and nude mice bearing human tumor xenografts.
Demignot S; Pimm MV; Baldwin RW
Cancer Res; 1990 May; 50(10):2936-42. PubMed ID: 2334894
[TBL] [Abstract][Full Text] [Related]
12. Binding parameters and idiotypic profile of the whole immunoglobulin and Fab' fragments of murine monoclonal antibody to distinct determinants of the human high molecular weight-melanoma associated antigen.
Temponi M; Gold AM; Ferrone S
Cancer Res; 1992 May; 52(9):2497-503. PubMed ID: 1373670
[TBL] [Abstract][Full Text] [Related]
13. MicroPET/CT imaging of patient-derived pancreatic cancer xenografts implanted subcutaneously or orthotopically in NOD-scid mice using (64)Cu-NOTA-panitumumab F(ab')2 fragments.
Boyle AJ; Cao PJ; Hedley DW; Sidhu SS; Winnik MA; Reilly RM
Nucl Med Biol; 2015 Feb; 42(2):71-7. PubMed ID: 25456837
[TBL] [Abstract][Full Text] [Related]
14. Targeting human prostate cancer with 111In-labeled D2B IgG, F(ab')2 and Fab fragments in nude mice with PSMA-expressing xenografts.
Lütje S; van Rij CM; Franssen GM; Fracasso G; Helfrich W; Eek A; Oyen WJ; Colombatti M; Boerman OC
Contrast Media Mol Imaging; 2015; 10(1):28-36. PubMed ID: 24764162
[TBL] [Abstract][Full Text] [Related]
15. Overcoming the nephrotoxicity of radiometal-labeled immunoconjugates: improved cancer therapy administered to a nude mouse model in relation to the internal radiation dosimetry.
Behr TM; Sharkey RM; Sgouros G; Blumenthal RD; Dunn RM; Kolbert K; Griffiths GL; Siegel JA; Becker WS; Goldenberg DM
Cancer; 1997 Dec; 80(12 Suppl):2591-610. PubMed ID: 9406714
[TBL] [Abstract][Full Text] [Related]
16. Single-chain antibodies in pancreatic cancer.
Colcher D; Pavlinkova G; Beresford G; Booth BJ; Batra SK
Ann N Y Acad Sci; 1999 Jun; 880():263-80. PubMed ID: 10415872
[TBL] [Abstract][Full Text] [Related]
17. Regulation of antibody-mediated complement-dependent cytotoxicity by modulating the intrinsic affinity and binding valency of IgG for target antigen.
Wang B; Yang C; Jin X; Du Q; Wu H; Dall'Acqua W; Mazor Y
MAbs; 2020; 12(1):1690959. PubMed ID: 31829766
[TBL] [Abstract][Full Text] [Related]
18. Effect of antibody valency on interaction with cell-surface expressed HIV-1 and viral neutralization.
Cavacini LA; Emes CL; Power J; Duval M; Posner MR
J Immunol; 1994 Mar; 152(5):2538-45. PubMed ID: 7510748
[TBL] [Abstract][Full Text] [Related]
19. The effect of antigen concentration, antibody valency and size, and tumor architecture on antibody binding in multicell spheroids.
Langmuir VK; McGann JK; Buchegger F; Sutherland RM
Int J Rad Appl Instrum B; 1991; 18(7):753-64. PubMed ID: 1787084
[TBL] [Abstract][Full Text] [Related]
20. Tumor targeting by a multivalent single-chain Fv (scFv) anti-Lewis Y antibody construct.
Kelly MP; Lee FT; Tahtis K; Power BE; Smyth FE; Brechbiel MW; Hudson PJ; Scott AM
Cancer Biother Radiopharm; 2008 Aug; 23(4):411-23. PubMed ID: 18771345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
